down arrow

Akums Drugs

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE09XN01023
  • NSEID: AKUMS
  • BSEID: 544222
INR
439.00
9.25 (2.15%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.77 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Rs cr
Consolidate Annual Results
Mar'24
Mar'23
Net Sales
4,178.18
3,654.82
Other Operating Income
0.00
0.00
Total Operating income
4,178.18
3,654.82
Raw Material Cost
2,278.37
2,028.09
Purchase of Finished goods
259.53
221.79
(Increase) / Decrease In Stocks
12.34
24.04
Employee Cost
646.86
590.13
Power Cost
0.00
0.00
Manufacturing Expenses
357.77
-43.98
Selling and Distribution Expenses
0.00
0.00
Other Expenses
500.33
496.80
Total Expenditure (Excl Depreciation)
4,055.20
3,316.87
Operating Profit (PBDIT) excl Other Income
122.98
337.95
Other Income
34.03
46.11
Operating Profit (PBDIT)
157.01
384.06
Interest
50.61
46.25
Exceptional Items
-26.03
-74.50
Gross Profit (PBDT)
80.37
263.31
Depreciation
125.64
112.81
Profit Before Tax
-45.28
150.50
Tax
-46.07
52.48
Provisions and contingencies
0.00
0.00
Profit After Tax
0.79
98.02
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
0.79
98.02
Share in Profit of Associates
0.00
-0.20
Minority Interest
-4.83
0.00
Other related items
0.00
0.00
Consolidated Net Profit
-4.04
97.82
Equity Capital
28.61
28.61
Face Value
2.0
2.0
Reserves
680.89
688.58
Earnings per share (EPS)
-0.28
6.84
Diluted Earnings per share
-0.28
6.63
Operating Profit Margin (Excl OI)
2.94%
9.25%
Gross Profit Margin
1.92%
7.2%
PAT Margin
0.02%
2.68%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 12.22% vs 10.74% in Mar 2023

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2024 is -231.91% vs 132.85% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is -152.36% vs 166.81% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 38.92% vs 261.10% in Mar 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2024 has fallen from Mar 2023

Compare Annual Results Of Akums Drugs With
Markets Mojo
Figures in Rs cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
4,178.18
10,334.77
-6,156.59
-59.57%
Other Operating Income
0.00
0.00
0.00
Total Operating income
4,178.18
10,334.77
-6,156.59
-59.57%
Raw Material Cost
2,278.37
1,853.52
424.85
22.92%
Purchase of Finished goods
259.53
1,409.85
-1,150.32
-81.59%
(Increase) / Decrease In Stocks
12.34
-53.67
66.01
122.99%
Employee Cost
646.86
2,274.73
-1,627.87
-71.56%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
357.77
0.00
357.77
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
500.33
2,315.28
-1,814.95
-78.39%
Total Expenditure (Excl Depreciation)
4,055.20
7,799.71
-3,744.51
-48.01%
Operating Profit (PBDIT) excl Other Income
122.98
2,535.06
-2,412.08
-95.15%
Other Income
34.03
280.86
-246.83
-87.88%
Operating Profit (PBDIT)
157.01
2,815.92
-2,658.91
-94.42%
Interest
50.61
33.53
17.08
50.94%
Exceptional Items
-26.03
0.00
-26.03
Gross Profit (PBDT)
80.37
2,782.39
-2,702.02
-97.11%
Depreciation
125.64
398.25
-272.61
-68.45%
Profit Before Tax
-45.28
2,384.14
-2,429.42
-101.90%
Tax
-46.07
457.58
-503.65
-110.07%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
0.79
1,926.56
-1,925.77
-99.96%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
0.79
1,926.56
-1,925.77
-99.96%
Share in Profit of Associates
0.00
15.21
-15.21
-100.00%
Minority Interest
-4.83
-28.87
24.04
83.27%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-4.04
1,912.90
-1,916.94
-100.21%
Equity Capital
28.61
40.06
-11.45
-28.58%
Face Value
2.00
1.00
0.00
Reserves
680.89
9,323.03
-8,642.14
-92.70%
Earnings per share (EPS)
-0.28
47.75
-48.03
-100.59%
Diluted Earnings per share
-0.28
47.68
-47.96
-100.59%
Operating Profit Margin (Excl OI)
2.94%
24.53%
0.00
-21.59%
Gross Profit Margin
1.92%
26.92%
0.00
-25.00%
PAT Margin
0.02%
18.79%
0.00
-18.77%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 1,444.12 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 12.22% vs 10.74% in Mar 2023

Annual - Standalone Net Profit
Standalone Net Profit -165.45 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -231.91% vs 132.85% in Mar 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -126.66 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -152.36% vs 166.81% in Mar 2023

Annual - Interest
Interest 18.31 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 38.92% vs 261.10% in Mar 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -8.77%
in Mar 2024

Figures in Rs %
stock-summary

YoY Growth in year ended Mar 2024 has fallen from Mar 2023